Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Treatment of Alzheimer disease.

Winslow BT, Onysko MK, Stob CM, Hazlewood KA.

Am Fam Physician. 2011 Jun 15;83(12):1403-12. Erratum in: Am Fam Physician. 2014 Aug 15;90(4):209.

2.

Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.

Bullock R.

Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):23-9. Review.

PMID:
16493232
3.

What is the rationale for new treatment strategies in Alzheimer's disease?

Rogawski MA.

CNS Spectr. 2004 Jul;9(7 Suppl 5):6-12.

PMID:
15241294
4.

[Cholesterol inhibitor and memantine in symptomatic dementia therapy].

Rodda J, Carter J.

Praxis (Bern 1994). 2013 Feb 27;102(5):293-300; discussion 298-9. doi: 10.1024/1661-8157/a001209. Review. German. No abstract available.

PMID:
23446240
5.

Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.

Grossberg GT, Edwards KR, Zhao Q.

J Clin Pharmacol. 2006 Jul;46(7 Suppl 1):17S-26S. Review.

PMID:
16809811
6.

Alternative drug therapies for dementia.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2011 May;49(5):17-20. doi: 10.3928/02793695-20110407-03. Epub 2011 Apr 27.

PMID:
21553703
7.

[Antidementia drugs].

Müller-Spahn F, Sollberger D, Wollmer MA.

Ther Umsch. 2009 Jun;66(6):432-40. doi: 10.1024/0040-5930.66.6.432. Review. German.

PMID:
19496039
8.

Alzheimer disease and its management: a review.

Samanta MK, Wilson B, Santhi K, Kumar KP, Suresh B.

Am J Ther. 2006 Nov-Dec;13(6):516-26. Review.

PMID:
17122533
9.

Drugs for cognitive loss and dementia.

[No authors listed]

Treat Guidel Med Lett. 2013 Oct;11(134):95-100; quiz 1 p following p100.. Review.

PMID:
24081314
10.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003154.

PMID:
12917950
11.

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease.

Lopez OL, Becker JT, Wahed AS, Saxton J, Sweet RA, Wolk DA, Klunk W, Dekosky ST.

J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):600-7. doi: 10.1136/jnnp.2008.158964. Epub 2009 Feb 9. Erratum in: J Neurol Neurosurg Psychiatry. 2009 Sep 1;80(9):1056.

12.

A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors.

Jones RW.

Int J Geriatr Psychiatry. 2010 Jun;25(6):547-53. doi: 10.1002/gps.2384. Review.

PMID:
20049770
13.

Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).

Olin JT, Bhatnagar V, Reyes P, Koumaras B, Meng X, Brannan S.

Int J Geriatr Psychiatry. 2010 Apr;25(4):419-26. doi: 10.1002/gps.2355.

PMID:
19670390
14.
15.

[Modern therapy for dementia].

Padberg F, Möller HJ, Bottlender R, Hampel H.

MMW Fortschr Med. 2005 May 17;147 Spec No 2:71-4, 76-7. German.

PMID:
15968877
16.

Memantine for dementia.

Areosa Sastre A, McShane R, Sherriff F.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003154. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD003154.

PMID:
15495043
17.

[Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial].

Hu HT, Zhang ZX, Yao JL, Yu HZ, Wang YH, Tang HC, Ji CJ, Xu T.

Zhonghua Nei Ke Za Zhi. 2006 Apr;45(4):277-80. Chinese.

PMID:
16780671
18.

Memantine in Alzheimer's disease: experience in an Alzheimer's disease assessment unit.

Sinforiani E, Pasotti C, Chiapella L, Malinverni P, Zucchella C.

Aging Clin Exp Res. 2012 Apr;24(2):193-6.

PMID:
22842837
19.

Memantine: a new approach to Alzheimer's disease.

Keltner NL, Williams B.

Perspect Psychiatr Care. 2004 Jul-Sep;40(3):123-4. No abstract available.

PMID:
15515294
20.

[Medical treatment of Alzheimer's disease].

Johannsen P.

Ugeskr Laeger. 2006 Oct 2;168(40):3424-9. Review. Danish.

PMID:
17032609

Supplemental Content

Support Center